Abstract:Interferons (IFNs) are multifunctional cytokines that after binding to the cell surface receptor induce the expression of a large number of genes, which in turn, mediate many biological processes including host defense, cell growth control, signaling, and metabolism. Here we show that IFN-alpha activates the mitogen-activated protein kinases (MAPK) ERK1/2 and the transcription factor CREB/ATF-1, which lead to the alpha-enolase (alpha-ENO) gene expression in fibroblasts. Alpha-ENO mRNA accumulation was apparent… Show more
“…Although Pla-induced signal transduction pathways have been analyzed in vitro in a few previous reports (19,21,23,24,31,33), the signaling pathways that govern Pla-induced cell migration in vivo have not been studied in detail. It has been shown that Plg/Pla activates ERK1/2 in fibroblasts (20,21,23,24), monocytes (31), and dendritic cells (33). We have previously shown that Plg/Pla activates the MEK/ERK pathway, leading to the expression of the transcription factors c-fos and Egr-1 (20), which in turn promotes a-enolase expression (23,24), an important Plg receptor that mediates monocyte recruitment in vivo (14).…”
Section: Discussionmentioning
confidence: 99%
“…1B) in a time-dependent manner. Because we have previously demonstrated that the MEK/ERK pathway is involved in Plg-induced gene expression in fibroblasts and monocytes (20,23,24), and it is known to be involved in cell motility (30), we wondered whether such pathway could underlie the Pla-induced migration in these cells. Interestingly, cell migration was associated with increased phosphorylation of ERK1/2 in both cell types (Fig.…”
Section: Pla-induced In Vitro Cell Migration Is Dependent On Mek/erk mentioning
confidence: 99%
“…We have previously demonstrated that the proinflammatory cytokine IFN-a increased the expression of the Plg receptor a-enolase on the surface of human monocytes with a consequent increase of Pla generation and proteolysis (23). Furthermore, IFN-a and Plg-induced expression of a-enolase was dependent on the MEK/ERK pathway (23,24).…”
mentioning
confidence: 99%
“…Pla also triggers multiple signaling pathways such as JAK/STAT, p38 MAPK, and ERK1/2 (18)(19)(20) and it has been shown to activate protease-activated receptor-1 (PAR-1) in fibroblasts (21,22). We have previously demonstrated that the proinflammatory cytokine IFN-a increased the expression of the Plg receptor a-enolase on the surface of human monocytes with a consequent increase of Pla generation and proteolysis (23). Furthermore, IFN-a and Plg-induced expression of a-enolase was dependent on the MEK/ERK pathway (23,24).…”
The plasminogen (Plg)/plasmin (Pla) system is associated with a variety of biological activities beyond the classical dissolution of fibrin clots, including cell migration, tissue repair, and inflammation. Although the capacity of Plg/Pla to induce cell migration is well defined, the mechanism underlying this process in vivo is elusive. In this study, we show that Pla induces in vitro migration of murine fibroblasts and macrophages (RAW 264.7) dependent on the MEK/ERK pathway and by requiring its proteolytic activity and lysine binding sites. Plasmin injection into the pleural cavity of BALB/c mice induced a time-dependent influx of mononuclear cells that was associated with augmented ERK1/2 and IκB-α phosphorylation and increased levels of CCL2 and IL-6 in pleural exudates. The inhibition of protease activity by using a serine protease inhibitor leupeptin or two structurally different protease-activated receptor-1 antagonists (SCH79797 and RWJ56110) abolished Pla-induced mononuclear recruitment and ERK1/2 and IκB-α phosphorylation. Interestingly, inhibition of the MEK/ERK pathway abolished Pla-induced CCL2 upregulation and mononuclear cell influx. In agreement with a requirement for the CCL2/CCR2 axis to Pla-induced cell migration, the use of a CCR2 antagonist (RS504393) prevented the Plg/Pla-induced recruitment of mononuclear cells to the pleural cavity and migration of macrophages at transwell plates. Therefore, Pla-induced mononuclear cell recruitment in vivo was dependent on protease-activated receptor-1 activation of the MEK/ERK/NF-κB pathway, which led to the release of CCL2 and activation of CCR2.
“…Although Pla-induced signal transduction pathways have been analyzed in vitro in a few previous reports (19,21,23,24,31,33), the signaling pathways that govern Pla-induced cell migration in vivo have not been studied in detail. It has been shown that Plg/Pla activates ERK1/2 in fibroblasts (20,21,23,24), monocytes (31), and dendritic cells (33). We have previously shown that Plg/Pla activates the MEK/ERK pathway, leading to the expression of the transcription factors c-fos and Egr-1 (20), which in turn promotes a-enolase expression (23,24), an important Plg receptor that mediates monocyte recruitment in vivo (14).…”
Section: Discussionmentioning
confidence: 99%
“…1B) in a time-dependent manner. Because we have previously demonstrated that the MEK/ERK pathway is involved in Plg-induced gene expression in fibroblasts and monocytes (20,23,24), and it is known to be involved in cell motility (30), we wondered whether such pathway could underlie the Pla-induced migration in these cells. Interestingly, cell migration was associated with increased phosphorylation of ERK1/2 in both cell types (Fig.…”
Section: Pla-induced In Vitro Cell Migration Is Dependent On Mek/erk mentioning
confidence: 99%
“…We have previously demonstrated that the proinflammatory cytokine IFN-a increased the expression of the Plg receptor a-enolase on the surface of human monocytes with a consequent increase of Pla generation and proteolysis (23). Furthermore, IFN-a and Plg-induced expression of a-enolase was dependent on the MEK/ERK pathway (23,24).…”
mentioning
confidence: 99%
“…Pla also triggers multiple signaling pathways such as JAK/STAT, p38 MAPK, and ERK1/2 (18)(19)(20) and it has been shown to activate protease-activated receptor-1 (PAR-1) in fibroblasts (21,22). We have previously demonstrated that the proinflammatory cytokine IFN-a increased the expression of the Plg receptor a-enolase on the surface of human monocytes with a consequent increase of Pla generation and proteolysis (23). Furthermore, IFN-a and Plg-induced expression of a-enolase was dependent on the MEK/ERK pathway (23,24).…”
The plasminogen (Plg)/plasmin (Pla) system is associated with a variety of biological activities beyond the classical dissolution of fibrin clots, including cell migration, tissue repair, and inflammation. Although the capacity of Plg/Pla to induce cell migration is well defined, the mechanism underlying this process in vivo is elusive. In this study, we show that Pla induces in vitro migration of murine fibroblasts and macrophages (RAW 264.7) dependent on the MEK/ERK pathway and by requiring its proteolytic activity and lysine binding sites. Plasmin injection into the pleural cavity of BALB/c mice induced a time-dependent influx of mononuclear cells that was associated with augmented ERK1/2 and IκB-α phosphorylation and increased levels of CCL2 and IL-6 in pleural exudates. The inhibition of protease activity by using a serine protease inhibitor leupeptin or two structurally different protease-activated receptor-1 antagonists (SCH79797 and RWJ56110) abolished Pla-induced mononuclear recruitment and ERK1/2 and IκB-α phosphorylation. Interestingly, inhibition of the MEK/ERK pathway abolished Pla-induced CCL2 upregulation and mononuclear cell influx. In agreement with a requirement for the CCL2/CCR2 axis to Pla-induced cell migration, the use of a CCR2 antagonist (RS504393) prevented the Plg/Pla-induced recruitment of mononuclear cells to the pleural cavity and migration of macrophages at transwell plates. Therefore, Pla-induced mononuclear cell recruitment in vivo was dependent on protease-activated receptor-1 activation of the MEK/ERK/NF-κB pathway, which led to the release of CCL2 and activation of CCR2.
“…Western blot analysis for the Ang-(1-7) Mas receptor was performed, as described previously by Sousa et al (30), in periarticular tissues, which include connective soft tissues that surround bone and cartilage and also the synovial membrane, from AIA and control animals. A rabbit polyclonal anti-Mas Ab (Novus Biologicals, Littleton, CO) was used at the dilution of 1:1000.…”
Section: Mas Expression In Articular Tissuesmentioning
Activation of the renin-angiotensin (Ang) system induces inflammation via interaction between Ang II and type 1 receptor on leukocytes. The relevance of the new arm of the renin-Ang system, namely Ang-converting enzyme-2/Ang-(1–7)/Mas receptor, for inflammatory responses is not known and was investigated in this study. For this purpose, two experimental models were used: Ag-induced arthritis (AIA) in mice and adjuvant-induced arthritis (AdIA) in rats. Male C57BL/6 wild-type or Mas−/− mice were subjected to AIA and treated with Ang-(1–7), the Mas agonist AVE 0991, or vehicle. AdIA was performed in female rats that were given AVE 0991 or vehicle. In wild-type mice, Mas protein is expressed in arthritic joints. Administration of AVE 0991 or Ang-(1–7) decreased AIA-induced neutrophil accumulation, hypernociception, and production of TNF-α, IL-1β, and CXCL1. Histopathological analysis showed significant reduction of inflammation. Mechanistically, AVE 0991 reduced leukocyte rolling and adhesion, even when given after Ag challenge. Mas−/− mice subjected to AIA developed slightly more pronounced inflammation, as observed by greater neutrophil accumulation and cytokine release. Administration of AVE 0991 was without effect in Mas−/− mice subjected to AIA. In rats, administration of AVE 0991 decreased edema, neutrophil accumulation, histopathological score, and production of IL-1β and CXCL1 induced by AdIA. Therefore, activation of Mas receptors decreases neutrophil influx and cytokine production and causes significant amelioration of arthritis in experimental models of arthritis in rats and mice. This approach might represent a novel therapeutic opportunity for arthritis.
HIV-1 transmission and spread involves significant host-virus interaction. Possible targets for obstacle of HIV-1 lie at the site of mucosal barriers. Thus a better understanding of how HIV-1 infects target cells at such sites and leads their invasion is required, with prime focus on the host determinants regulating HIV-1 spread. For the viral infectivity and pathogenicity, HIV-1 Nef facilitates immune evasion through protein-protein interactions within host cell. HIV-1 Nef is significant for viral infectivity and pathogenicity. It enhances HIV-1 replication, facilitating immune evasion by interacting with various host factors and altering cellular pathways via multiple protein-protein interactions. In this study, HIV-1 Nef forms with specific mutations, revealing sequence variability, were studied for their effects in human SupT1 T cell line and (THP-1) monocyte-macrophage cell line. Proteins being downregulated by Nef in SupT1 were further observed in THP-1, and interestingly two host proteins' (ENO-1 and VDAC1) expression was found to be cell lineage specific, being stimulatory in macrophages/monocytes and inhibitory in T cells. Cell migration, invasion and ADP release studies were employed to determine the biological function affected by Nef-mediated regulation of these two host proteins. ENO1-regulated function: cell invasion was enhanced in THP-1 cells, but was inhibited in SupT1 cells by Nef RP01. In addition, the modulation of proteins and cell invasion remained unaffected by a Nef RP14. These results indicated that regulation of host protein expression and invasive property of host cells by Nef was sequence specific, suggesting involvement of a particular motif of Nef. To precisely determine this site, we designed a heptapeptide including the CAWLEAQ-regulating sequence of Nef. Macrophages/monocytes being the major cells affected by HIV-1 at mucosal barriers were particularly investigated by the peptide. The peptide led to reversal of differential expressions of ENO1 in both SupT1 and THP-1 and inhibition of enhanced invasiveness in THP-1 cells. Further AP-1 was identified as a factor involved in this Nef-mediated regulation of host proteins. Together these findings suggest a possible mechanism of host invasion by HIV-1 through the CAWLEAQ motif of Nef-mediated regulation of ENO1 and identify a potential therapeutic target for HIV-1 entry at mucosal barriers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.